bioAffinity Technologies, Inc. – NASDAQ:BIAFW

Add to watchlist

$0.1

-0.23

-70.27%

Market closed

Open in about 8 hours

-45.81%

month

-45.81%

quarter

+273.33%

year

Market Cap	4.67M
Enterprise value	N/A

P/E	N/A
EV/Sales	N/A
EV/EBITDA	N/A
Price/Sales	N/A
Price/Book	N/A
PEG ratio	N/A
EPS	-0.91

Revenue	4.93M
EBITDA	-7.94M
Income	-8.36M
Revenue Q/Q	261180.23%
Revenue Y/Y	86182.87%

Profit margin	-201288.92%
Oper. margin	-94469.1%
Gross margin	90.28%
EBIT margin	-94469.1%
EBITDA margin	-160.92%

Get more financial ratios!

Every financial ratio you might need
10 years history
Forward ratios (Analysts estimates)

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

bioAffinity Technologies, Inc. (NASDAQ:BIAFW): Profit margin
Jun 2023	19.73K	-1.74M	-8816.36%
Sep 2023	298.48K	-2.29M	-767.51%
Dec 2023	2.21M	-2.37M	-107.22%
Mar 2024	2.40M	-1.96M	-81.53%

bioAffinity Technologies, Inc. (NASDAQ:BIAFW): Debt to assets
Jun 2023	8873499	775.15K	8.74%
Sep 2023	10189464	3.19M	31.36%
Dec 2023	8221552	3.36M	40.94%
Mar 2024	8049265	2.79M	34.69%

bioAffinity Technologies, Inc. (NASDAQ:BIAFW): Cash Flow
Jun 2023	-1.35M	-3.86K	-126.09K
Sep 2023	-1.53M	-2.18M	-50.76K
Dec 2023	-1.61M	13.44K	-84.80K
Mar 2024	-2.34M	-41.38K	2.01M

bioAffinity Technologies alternative data

bioAffinity Technologies
Employees

bioAffinity Technologies, Inc. (NASDAQ:BIAFW): Employee count
Jan 2024	14
Feb 2024	14
Apr 2024	14
May 2024	14
Jun 2024	14
Jul 2024	14

bioAffinity Technologies
Insider Trading

bioAffinity Technologies, Inc. (NASDAQ:BIAFW): Insider trades (number of shares)
Period	Buy	Sel
Jul 2022	165628	0
Aug 2022	220704	0
Sep 2022	421421	0

Transaction	Date	Insider	Security	Shares	Price per share	Total value
Purchase	6 Sep 2022	GIRGENTI STEVEN director, officer: Executive Chairman director, officer: Executive Ch..	Warrants (right to buy)	5,952	$6.13	$36,456
Purchase	6 Sep 2022	RUBIN GARY D director, 10 percent owner director, 10 percent owner	Warrants (right to buy)	408,125	$6.13	$2,499,766
Purchase	1 Sep 2022	EDWARDS JAMES MICHAEL officer: Chief Financial Officer officer: Chief Financial Officer	Non-tradeable Warrants (right to buy)	4,896	$7.66	$37,484
Purchase	1 Sep 2022	EDWARDS JAMES MICHAEL officer: Chief Financial Officer officer: Chief Financial Officer	Common Stock, par value $0.007	2,448	N/A	N/A
Purchase	31 Aug 2022	ZANNES MARIA director, officer: President, CEO director, officer: President, CEO	Non-tradeable Warrants (right to buy)	32,652	$7.66	$249,984
Purchase	31 Aug 2022	ZANNES MARIA director, officer: President, CEO director, officer: President, CEO	Common Stock	16,326	N/A	N/A
Purchase	31 Aug 2022	GIRGENTI STEVEN director, officer: Executive Chairman director, officer: Executive Ch..	Non-tradeable Warrants (right to buy)	81,832	$7.66	$626,506
Purchase	31 Aug 2022	GIRGENTI STEVEN director, officer: Executive Chairman director, officer: Executive Ch..	Common Stock	40,916	N/A	N/A
Purchase	31 Aug 2022	RUBIN GARY D director, 10 percent owner director, 10 percent owner	Non-tradeable Warrants (right to buy)	32,652	$7.66	$249,984
Purchase	31 Aug 2022	RUBIN GARY D director, 10 percent owner director, 10 percent owner	Common Stock	16,326	N/A	N/A

BIAFW insider trading transactions

Frequently Asked Questions (FAQ)

What's the price of bioAffinity Technologies stock today?

One share of bioAffinity Technologies stock can currently be purchased for approximately $0.1.
When is bioAffinity Technologies's next earnings date?

Unfortunately, bioAffinity Technologies's (BIAFW) next earnings date is currently unknown.
Does bioAffinity Technologies pay dividends?

No, bioAffinity Technologies does not pay dividends.
How much money does bioAffinity Technologies make?

bioAffinity Technologies has a market capitalization of 4.67M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 52627.44% to 2.53M US dollars.
What is bioAffinity Technologies's stock symbol?

bioAffinity Technologies, Inc. is traded on the NASDAQ under the ticker symbol "BIAFW".
What is bioAffinity Technologies's primary industry?

Company operates in the Healthcare sector and Medical - Diagnostics & Research industry.
How do i buy shares of bioAffinity Technologies?

Shares of bioAffinity Technologies can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
How many employees does bioAffinity Technologies have?

As Jul 2024, bioAffinity Technologies employs 14 workers.
What is bioAffinity Technologies's official website?

The official website for bioAffinity Technologies is bioaffinitytech.com.

bioAffinity Technologies, Inc.

bioaffinitytech.com

Exchange:

NASDAQ

Full time employees:

Industry:

Medical - Diagnostics & Research

Sector:

Healthcare

bioAffinity Technologies, Inc. operates as a development-stage company addressing the significant unmet need for non-invasive, early-stage cancer diagnosis and treatment. The firm develops proprietary in-vitro diagnostic tests and targeted cancer therapeutics using breakthrough technology that preferentially targets cancer cells. The company was founded on March 26, 2014 and is headquartered in San Antonio, TX.

CIK: 0001712762
ISIN: US09076W1172
CUSIP: 09076W117